Skip to main content


Jakob Mühlbacher Jakob Mühlbacher

Department of Surgery (Division of General Surgery)
Position: Consultant

ORCID: 0000-0002-8592-8259
T +43 1 40400 56210

Further Information


Carcinoma, Pancreatic Ductal; Complement System Proteins; Critical Illness; Intensive Care; Kidney Transplantation

Research group(s)


  • Torque Teno Virus for the prediction of humoral alloreactivity in liver transplant recipients. (2019)
    Source of Funding: Medical Scientific Fund of the Mayor of the City of Vienna, Clinical Research
    Principal Investigator

Selected publications

  1. Mühlbacher, J. et al., 2020. Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients. Frontiers in Medicine, 7. Available at:
  2. Mühlbacher, J. et al., 2019. Feasibility of ultrasound measurement in a human model of acute compartment syndrome. World Journal of Emergency Surgery, 14(1). Available at:
  3. Eskandary, F. et al., 2017. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial. American Journal of Transplantation, 18(4), pp.916–926. Available at:
  4. Mühlbacher, J. et al., 2017. Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial. Transplantation, 101(10), pp.2410–2418. Available at:
  5. Wahrmann, M. et al., 2017. Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study. American Journal of Transplantation, 17(9), pp.2300–2311. Available at: